A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye.
about
Rebamipide ophthalmic suspension for the treatment of dry eye syndrome: a critical appraisal.Downregulation of IL-8, ECP, and total IgE in the tears of patients with atopic keratoconjunctivitis treated with rebamipide eyedrops.Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye.Effectiveness and relevant factors of 2% rebamipide ophthalmic suspension treatment in dry eye.In Vivo and Impression Cytology Study on the Effect of Compatible Solutes Eye Drops on the Ocular Surface Epithelial Cell Quality in Dry Eye PatientsAnti-inflammatory effects of hinokitiol on human corneal epithelial cells: an in vitro studyEffect of topical rebamipide on conjunctival goblet cell recovery after vitrectomy.Do Cyclosporine A, an IL-1 Receptor Antagonist, Uridine Triphosphate, Rebamipide, and/or Bimatoprost Regulate Human Meibomian Gland Epithelial Cells?Changing trends in the treatment of dry-eye disease.The Future of Dry Eye Treatment: A Glance into the Therapeutic Pipeline.Regulation of human corneal epithelial mucins by rebamipide.Diagnostic procedures and management of dry eye.Persistent corneal epithelial defect responding to rebamipide ophthalmic solution in a patient with diabetes.Efficacy and safety of retinol palmitate ophthalmic solution in the treatment of dry eye: a Japanese Phase II clinical trial.Rebamipide protects against glaucoma eyedrop-induced ocular surface disorders in rabbits.Use of the Controlled Adverse Environment (CAE) in Clinical Research: A Review.A Prospective, Randomized Trial of Two Mucin Secretogogues for the Treatment of Dry Eye Syndrome in Office Workers.Efficacy of Rebamipide Instillation for Contact Lens Discomfort With Dry Eye.Ocular Effects of Sulfur Mustard and Therapeutic Approaches.Rebamipide suppresses TNF-α production and macrophage infiltration in the conjunctiva.Therapeutic inhibitors for the treatment of dry eye syndrome.Inhibition by rebamipide of cytokine-induced or lipopolysaccharide-induced chemokine synthesis in human corneal fibroblasts.Current and emerging therapy of dry eye disease. Part A: pharmacological modalitiesA Comprehensive Review on Dry Eye Disease: Diagnosis, Medical Management, Recent Developments, and Future Challenges
P2860
Q33734688-AE8F6273-E7EB-4F39-9FF5-545CBAED55D0Q35103015-CC2C370C-437A-42F8-9C19-08BD88829B9DQ35223432-B9A3324E-783B-48C5-A39C-CA919A27FF38Q35655084-5460B809-39F7-46E7-A372-696F1D5A7B0CQ35843885-DB6C28D4-75B1-4374-A653-80A243FCEC17Q35863016-F0A46856-1C76-4AF3-AE89-6E8DDEDF9F42Q36499458-46C0B91A-A2EA-4BAB-8615-7B6F58D5AFFEQ37242107-C552A715-643B-4FD2-A464-3F0A027D9F37Q38148616-AC510295-9482-4666-96DC-94C70ADD7D67Q38569837-8EA0B1E4-4C44-4773-8C57-F3680FD0E33BQ39090645-F50ADAF8-C720-4F7E-A1E2-D8F8A022199AQ39352252-262C7716-1D47-4752-AF30-D6FF7B0384EAQ40647505-8EF15975-BF05-46FC-92E4-8C3C2A316892Q40997622-C1866987-192B-4050-BACD-E6E4175D698CQ42877954-A659423C-6975-4F7A-B4A3-FEFDE27DEC2FQ47100458-BE6F8EEB-1AE8-4FCD-9FFC-D52A00DC8181Q47121635-ABCBD97A-561E-4419-988E-08B16C85C5C7Q47405249-ADF57B38-5CF2-4D85-A9CC-14FBCC4AF6B2Q47993522-AB05DBD4-0BBF-4C47-8FC0-6B347F500671Q49686792-7ED4853D-3DBE-4FF2-8305-357EE72707EEQ50110517-F26CDBCE-3286-4528-A300-7AF6B4E2AD40Q54194248-9D3DCE14-422C-49AB-8327-D8C0E650FC89Q57378488-BE9D1371-67E9-4DEB-8817-1E20C874C252Q59104204-D6698140-A0F3-4C0D-91C4-2DC163584672
P2860
A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A randomized, multicenter phas ...... e in the treatment of dry eye.
@ast
A randomized, multicenter phas ...... e in the treatment of dry eye.
@en
A randomized, multicenter phas ...... e in the treatment of dry eye.
@nl
type
label
A randomized, multicenter phas ...... e in the treatment of dry eye.
@ast
A randomized, multicenter phas ...... e in the treatment of dry eye.
@en
A randomized, multicenter phas ...... e in the treatment of dry eye.
@nl
prefLabel
A randomized, multicenter phas ...... e in the treatment of dry eye.
@ast
A randomized, multicenter phas ...... e in the treatment of dry eye.
@en
A randomized, multicenter phas ...... e in the treatment of dry eye.
@nl
P2093
P1433
P1476
A randomized, multicenter phas ...... e in the treatment of dry eye.
@en
P2093
Hiroyuki Suzuki
Kazuhide Oshiden
Norihiko Yokoi
Norihiro Nakamichi
Rebamipide Ophthalmic Suspension Phase 3 Study Group
Saki Awamura
Shigeru Kinoshita
P304
P356
10.1016/J.OPHTHA.2012.12.022
P577
2013-03-13T00:00:00Z